You are here
P&T News
January 29
Caps are ‘very small idea,’ experts says
Companies strike discount deals
Study shows strong association for first time
Devices have history of malfunction issues
Scientists find novel way to kill resistant bacteria
January 28
Commonly used drugs eradicate cancer stem cells
Merck mumps vaccine is on the hot seat
First percutaneous single-access pump for right heart support
Company seeks expanded indication
Product slated for launch in first quarter of 2015
January 27
Fears based on flawed studies, article says
Iron compound delivered to hemodialysis patients via dialysate
FDA’s approval decision expected in July
Half of annual payments would go to health care providers by end of 2018
Expensive treatments could test insurers’ ability to pay for them, report says
January 26
Highest obesity rate in 7 years
Authors call for improved patient education
Data-sharing capability allows caregivers to monitor patient’s blood sugar levels remotely
Rare disease affects about 60,000 people in U.S.
Vaccine granted ‘breakthrough therapy’ status
January 23
Paper-clip-sized implant inserted in upper thigh
Agency’s decision expected in March
Opioid exposure during pregnancy increases risk of birth defects
Mid-stage data show superiority over doxorubicin
Younger population more likely to be diagnosed with advanced disease, authors say
January 22
Patient wears small, external insulin pump
First IL-17A antagonist for moderate-to-severe plaque psoriasis
Scripps researchers recognize importance of molecular ‘handed-ness’
XRCC2 mutation may explain resistance to platinum-based therapy
Penalties wipe out rewards
January 21
Case could block doctors and hospitals from seeking higher rates
Reduced competition is part of the problem, expert says
Low-income families have greatest concern
Vaccine protects against 70% of cervical cancers
Product could be on the market by 2017
January 20
Risk of relapse reduced by half compared with placebo
Common disease kills more people each day than Ebola, expert says
Experts review the good, the bad, and the doubtful
Drugs have to keep up with ‘genomic drift’
Novel approach may lead to next generation of better, safer anesthetic agents
January 19
Global cost could reach $70 trillion over next decade
New formulation improves on once-monthly Invega Sustenna
NIH study finds most older people use alcohol-interactive medications
Mid-stage data support treatment’s immunostimulatory mechanism of action
Polymer nanoparticles release targeted drug molecules
January 16
Such products, defined in the guidance, do not require FDA oversight
The vaccine cuts the risk of having to visit a doctor by 23%
Federal judge approves consent decree with California firm that failed to follow regulations
Benefit shown in cases of wild-type RAS disease
Initiation of registrational studies planned for this year